You are on page 1of 2

NURS 1566 Clinical Form 3: Clinical Medications Worksheets Generic Name Trade Name Classification Dose Route Nalbuphine

Nubain Opioid analgesics 2mg IVP Peak Onset Duration Normal dosage range 30 min 2-3 min 3-6 hr 0.3-3mg/kg over 10-15 min Why is your patient getting this medication Pain r/t knee surgery Mechanism of action and indications (Why med ordered) Binds to opiate receptors in the CNS, alters the perception of and responses to painful stimuli while producing generalized CNS depression Time/frequency PRN

For IV meds, compatibility with IV drips and/or solutions Nursing Implications (what to focus on) Contraindications/warnings/interactions Hypersensitivity, hypothyroidism, Common side effects Dizziness, headache, sedation, dry mouth, nausea, vomiting, clammy feeling, sweating Lab value alterations caused by medicine

Y-Site Incompatibility: ♦cefepime ♦methotrexate ♦nafcillin ♦piperacillin/tazobactam ♦ sargramostim ♦sodium bicarbonate

Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically)

May cause increased serum amylase and lipase concentrations

Be sure to teach the patient the following about this medication

May cause drowsiness or dizziness. Advise patient to call for assistance when ambulating and to avoid driving or other activities requiring alertness until response to the medication is known. Caution patient to change positions slowly to minimize orthostatic hypotension. Advise patient that frequent mouth rinses, good oral hygiene, and sugarless gum or candy may decrease dry mouth. Encourage patient to turn, cough, and breathe deeply every 2 hr to prevent atelectasis

Nursing Process- Assessment (Pre-administration assessment)

Assess type, location, and intensity of pain before and 1 hr after IM or 30 min (peak) after IV administration. When titrating opioid doses, increases of 25-50% should be administered until there is either a 50% reduction in the patient's pain rating on a numeric or visual analogue scale or the patient reports satisfactory pain relief. A repeat dose can be safely administered at the time of the peak if previous dose is ineffective and side effects are minimal. Patients requiring doses higher than 20 mg should be converted to an opioid agonist. Assess blood pressure, pulse, and respirations before and periodically during administration. If respiratory rate is <10/min, assess level of sedation. Physical stimulation may be sufficient to prevent significant hypoventilation. Dose may need to be decreased by 25-50%.

Assessment Why would you hold or not give this med?

Evaluation Check after giving

Toxicity and Overdose: If an opioid antagonist is required to reverse respiratory depression or coma, naloxone (Narcan) is the antidote.

Decrease in severity of pain without significant alteration in level of consciousness or respiratory status